{
  "FBS": {
    "Normal": {
      "Range": [70, 99],
      "Age": {
        "Baby (0-2 years)": "N/A",
        "Child (3-12 years)": "N/A",
        "Young Adult (20-35 years)": "70–99 mg/dL",
        "Adult (36-64 years)": "70–99 mg/dL",
        "Senior (65+ years)": "70–99 mg/dL"
      },
      "Sex": {
        "Male": "70–99 mg/dL",
        "Female": "70–99 mg/dL"
      },
      "Medication": "None. Continue balanced diet and regular exercise.",
      "Dosage": {
        "Standard": "Not applicable."
      },
      "Count": "0",
      "Treatment": "Daily maintenance",
      "Reason": [
        "A fasting blood sugar between 70 and 99 mg/dL reflects normal glucose metabolism.",
        "This level is associated with a low risk of diabetes and cardiovascular complications.",
        "Adequate sleep, no smoking, and minimal alcohol consumption support these levels."
      ],
      "Conclusion": "Fasting blood sugar is within normal limits. Maintain your current lifestyle to sustain optimal glucose control. If not maintained, poor diet and lifestyle choices may gradually increase the risk for metabolic complications."
    },
    "Prediabetes": {
      "Range": [100, 125],
      "Age": {
        "Baby (0-2 years)": "Not applicable",
        "Child (3-12 years)": "Not applicable",
        "Young Adult (20-35 years)": "100–125 mg/dL; consider early intervention",
        "Adult (36-64 years)": "100–125 mg/dL; lifestyle changes are imperative",
        "Senior (65+ years)": "100–125 mg/dL; initiate careful monitoring and lifestyle adjustments"
      },
      "Sex": {
        "Male": "100–125 mg/dL; assess for insulin resistance",
        "Female": "100–125 mg/dL; assess for insulin resistance"
      },
      "Medication": "Lifestyle modification; consider metformin if needed.",
      "Dosage": {
        "Young Adult (20-35 years)": "Metformin 500 mg twice daily with meals, titrate as needed.",
        "Adult (36-64 years)": "Metformin 500 mg three times daily with meals; adjust based on response.",
        "Senior (65+ years)": "Metformin 500 mg twice daily with meals, starting at the lowest dose with renal monitoring."
      },
      "Count": "15",
      "Treatment": "As prescribed",
      "Reason": [
        "Fasting blood sugar in the 100–125 mg/dL range indicates impaired fasting glucose and increased risk for type 2 diabetes.",
        "Risk factors such as poor sleep, smoking, and excessive alcohol consumption can exacerbate insulin resistance.",
        "Early intervention with lifestyle changes can prevent or delay progression to overt diabetes."
      ],
      "Conclusion": "Fasting blood sugar is in the prediabetic range. Intensify lifestyle modifications (including improving sleep habits, smoking cessation, and reducing alcohol intake) and consider pharmacologic intervention if necessary. Failure to address these issues may lead to full-blown diabetes and its complications."
    },
    "Diabetes": {
      "Range": [126, null],
      "Age": {
        "Baby (0-2 years)": "Not applicable",
        "Child (3-12 years)": "Requires pediatric endocrinology evaluation",
        "Young Adult (20-35 years)": "≥126 mg/dL; requires prompt management",
        "Adult (36-64 years)": "≥126 mg/dL; confirm diagnosis and initiate a comprehensive diabetes care plan",
        "Senior (65+ years)": "≥126 mg/dL; treatment should be individualized considering comorbidities"
      },
      "Sex": {
        "Male": "≥126 mg/dL; immediate management indicated",
        "Female": "≥126 mg/dL; immediate management indicated"
      },
      "Medication": "Metformin",
      "Dosage": {
        "Young Adult (20-35 years)": "Metformin 500 mg twice daily with meals, titrate as needed.",
        "Adult (36-64 years)": "Metformin 500 mg three times daily with meals; adjust dose based on response.",
        "Senior (65+ years)": "Metformin 500 mg twice daily with meals; start at a low dose with renal monitoring."
      },
      "Count": "15",
      "Treatment": "As prescribed",
      "Reason": [
        "A fasting blood sugar ≥126 mg/dL is diagnostic for diabetes, indicating significant impairment in glucose regulation.",
        "Contributing factors such as chronic sleep deprivation, smoking, and heavy alcohol use further worsen glycemic control.",
        "Without treatment, there is a high risk for microvascular (neuropathy, retinopathy, nephropathy) and macrovascular (cardiovascular disease) complications."
      ],
      "Conclusion": "The fasting blood sugar level indicates diabetes. Initiate comprehensive diabetes management—including lifestyle modifications (improving sleep, smoking cessation, reducing alcohol intake) and pharmacotherapy (metformin)—to prevent severe complications. If not treated, the patient faces a high risk of organ damage and life-threatening events."
    }
  },
  "BUN": {
    "Range": [7, 20],
    "Age": {
      "Baby (0-2 years)": "7–18 mg/dL",
      "Child (3-12 years)": "7–18 mg/dL",
      "Young Adult (20-35 years)": "7–18 mg/dL",
      "Adult (36-64 years)": "7–20 mg/dL",
      "Senior (65+ years)": "7–20 mg/dL (may vary with renal function)"
    },
    "Sex": {
      "Male": "7–20 mg/dL",
      "Female": "7–20 mg/dL"
    },
    "Medication": "None required.",
    "Dosage": {
      "Standard": "Not applicable."
    },
    "Count": "0",
    "Treatment": "Daily maintenance",
    "Reason": [
      "Normal BUN indicates adequate kidney filtration and proper hydration."
    ],
    "Conclusion": "BUN is within normal limits. Maintain proper hydration and periodic renal monitoring to avoid dehydration or renal stress."
  },
  "Creatinine": {
    "Range": [0.6, 1.3],
    "Age": {
      "Baby (0-2 years)": "0.2–0.5 mg/dL",
      "Child (3-12 years)": "0.3–0.7 mg/dL",
      "Young Adult (20-35 years)": "0.6–1.1 mg/dL",
      "Adult (36-64 years)": "0.6–1.3 mg/dL",
      "Senior (65+ years)": "0.6–1.3 mg/dL (may vary with renal function)"
    },
    "Sex": {
      "Male": "0.6–1.3 mg/dL",
      "Female": "0.5–1.1 mg/dL"
    },
    "Medication": "No medication if normal; consult nephrology if elevated.",
    "Dosage": {
      "Standard": "Not applicable."
    },
    "Count": "0",
    "Treatment": "Daily maintenance",
    "Reason": [
      "Creatinine within normal limits reflects healthy renal function."
    ],
    "Conclusion": "Creatinine is normal. Continue routine monitoring to detect any early signs of renal impairment."
  },
  "Uric Acid": {
    "Range": [3.5, 7.2],
    "Current Level": "7.3 mg/dL",
    "Age": {
      "Baby (0-2 years)": "3.0–6.0 mg/dL",
      "Child (3-12 years)": "3.0–6.0 mg/dL",
      "Young Adult (20-35 years)": "3.5–7.2 mg/dL",
      "Adult (36-64 years)": "3.5–7.2 mg/dL",
      "Senior (65+ years)": "3.5–7.2 mg/dL"
    },
    "Sex": {
      "Male": "3.5–7.2 mg/dL",
      "Female": "2.6–6.0 mg/dL"
    },
    "Medication": "Allopurinol",
    "Dosage": {
      "Young Adult (20-35 years)": "Start at 100 mg once daily; titrate as needed.",
      "Adult (36-64 years)": "100–300 mg daily",
      "Senior (65+ years)": "Start at 100 mg once daily with careful monitoring; adjust dose as needed."
    },
    "Count": "15",
    "Treatment": "As treated",
    "Reason": [
      "A uric acid level at the upper limit or slightly above normal increases the risk for gout and renal calculi.",
      "Additional lifestyle factors such as poor diet, inadequate hydration, and alcohol consumption may contribute."
    ],
    "Conclusion": "Uric acid is mildly elevated. Recommend lifestyle modifications and initiate allopurinol if clinical gout symptoms develop. If untreated, there is an increased risk of gout attacks and kidney stone formation."
  },
  "Cholesterol": {
    "Range": [125, 200],
    "Current Level": "186.15 mg/dL",
    "Age": {
      "Baby (0-2 years)": "N/A",
      "Child (3-12 years)": "N/A",
      "Young Adult (20-35 years)": "125–200 mg/dL",
      "Adult (36-64 years)": "125–200 mg/dL",
      "Senior (65+ years)": "125–200 mg/dL"
    },
    "Sex": {
      "Male": "125–200 mg/dL",
      "Female": "125–200 mg/dL"
    },
    "Medication": "Atorvastatin",
    "Dosage": {
      "Young Adult (20-35 years)": "Atorvastatin 10 mg once daily; adjust based on LDL goals.",
      "Adult (36-64 years)": "Atorvastatin 20–40 mg once daily; titrate as needed.",
      "Senior (65+ years)": "Atorvastatin 10–20 mg once daily; consider comorbidities."
    },
    "Count": "15",
    "Treatment": "As treated",
    "Reason": [
      "Cholesterol within this range is generally desirable; however, other risk factors (e.g., smoking, sedentary lifestyle) may increase cardiovascular risk."
    ],
    "Conclusion": "Cholesterol is within normal limits. Advise a heart‑healthy diet, regular exercise, and risk factor modification. If left untreated in a high-risk individual, there is a potential for atherosclerotic cardiovascular disease."
  },
  "Triglycerides": {
    "Range": [0, 150],
    "Current Level": "186.36 mg/dL",
    "Age": {
      "Baby (0-2 years)": "N/A",
      "Child (3-12 years)": "N/A",
      "Young Adult (20-35 years)": "0–150 mg/dL",
      "Adult (36-64 years)": "0–150 mg/dL",
      "Senior (65+ years)": "0–150 mg/dL"
    },
    "Sex": {
      "Male": "0–150 mg/dL",
      "Female": "0–150 mg/dL"
    },
    "Medication": "Fenofibrate",
    "Dosage": {
      "Young Adult (20-35 years)": "Fenofibrate 145 mg once daily.",
      "Adult (36-64 years)": "Fenofibrate 145 mg once daily.",
      "Senior (65+ years)": "Fenofibrate 145 mg once daily; adjust if necessary."
    },
    "Count": "15",
    "Treatment": "As treated",
    "Reason": [
      "Elevated triglycerides are associated with increased cardiovascular risk and may indicate metabolic syndrome.",
      "Contributing factors include a high-fat diet, sedentary lifestyle, smoking, and alcohol intake."
    ],
    "Conclusion": "Triglyceride levels are elevated. Recommend strict dietary modifications, increased physical activity, and consider fibrate therapy. If not managed, there is an increased risk of cardiovascular events and pancreatitis."
  },
  "VLDL": {
    "Range": [5, 40],
    "Current Level": "35.77 mg/dL",
    "Age": {
      "Baby (0-2 years)": "N/A",
      "Child (3-12 years)": "N/A",
      "Young Adult (20-35 years)": "5–40 mg/dL",
      "Adult (36-64 years)": "5–40 mg/dL",
      "Senior (65+ years)": "5–40 mg/dL"
    },
    "Sex": {
      "Male": "5–40 mg/dL",
      "Female": "5–40 mg/dL"
    },
    "Medication": "Lifestyle modifications; statin therapy may be considered if indicated.",
    "Dosage": {
      "Standard": "Not applicable specifically for VLDL."
    },
    "Count": "0",
    "Treatment": "Daily maintenance",
    "Reason": [
      "Slightly elevated VLDL can contribute to atherogenesis and cardiovascular risk.",
      "Risk may be compounded by poor dietary habits and lack of exercise."
    ],
    "Conclusion": "VLDL is near the upper limit of normal. Recommend dietary fat reduction, weight management, and regular exercise. Untreated, it may contribute to the development of atherosclerosis."
  },
  "HDL": {
    "Range": [40, 65],
    "Current Level": "35.77 mg/dL",
    "Age": {
      "Baby (0-2 years)": "N/A",
      "Child (3-12 years)": "N/A",
      "Young Adult (20-35 years)": "40–65 mg/dL",
      "Adult (36-64 years)": "40–65 mg/dL",
      "Senior (65+ years)": "40–65 mg/dL"
    },
    "Sex": {
      "Male": "40–65 mg/dL",
      "Female": "40–65 mg/dL"
    },
    "Medication": "Niacin",
    "Dosage": {
      "Young Adult (20-35 years)": "Niacin 500 mg once daily, titrate gradually if tolerated.",
      "Adult (36-64 years)": "Niacin 500 mg twice daily with meals.",
      "Senior (65+ years)": "Niacin 500 mg once daily with food."
    },
    "Count": "15",
    "Treatment": "As treated",
    "Reason": [
      "Low HDL is a risk factor for cardiovascular disease; increasing HDL levels can reduce this risk.",
      "Contributing factors may include smoking, sedentary lifestyle, and poor diet."
    ],
    "Conclusion": "HDL is below target. Emphasize increased physical activity, improved diet, and consider niacin therapy. If not treated, low HDL increases the risk of cardiovascular events."
  },
  "LDL": {
    "Range": [0, 150],
    "Current Level": "114.62 mg/dL",
    "Age": {
      "Baby (0-2 years)": "N/A",
      "Child (3-12 years)": "N/A",
      "Young Adult (20-35 years)": "0–150 mg/dL",
      "Adult (36-64 years)": "0–150 mg/dL",
      "Senior (65+ years)": "0–150 mg/dL"
    },
    "Sex": {
      "Male": "0–150 mg/dL",
      "Female": "0–150 mg/dL"
    },
    "Medication": "Statins (if indicated)",
    "Dosage": {
      "Standard": "Initiate statin therapy per established guidelines if indicated by overall cardiovascular risk; otherwise, no medication is required."
    },
    "Count": "15",
    "Treatment": "As treated",
    "Reason": [
      "LDL within target range is generally reassuring; however, overall cardiovascular risk must be evaluated.",
      "Lifestyle factors such as smoking and poor diet can still contribute to cardiovascular risk."
    ],
    "Conclusion": "LDL is acceptable. Continue preventive measures including a healthy diet and regular exercise. Failure to address lifestyle risk factors may lead to atherosclerotic cardiovascular disease."
  },
  "CHOL/HDL Ratio": {
    "Range": [0, 4.5],
    "Current Level": "5.2",
    "Age": {
      "Baby (0-2 years)": "N/A",
      "Child (3-12 years)": "N/A",
      "Young Adult (20-35 years)": "0–4.5",
      "Adult (36-64 years)": "0–4.5",
      "Senior (65+ years)": "0–4.5"
    },
    "Sex": {
      "Male": "0–4.5",
      "Female": "0–4.5"
    },
    "Medication": "Lifestyle modifications; consider statin therapy if indicated.",
    "Dosage": {
      "Standard": "Refer to statin dosing guidelines if therapy is initiated."
    },
    "Count": "0",
    "Treatment": "Daily maintenance",
    "Reason": [
      "An elevated CHOL/HDL ratio is an independent predictor of cardiovascular events.",
      "Risk factors such as smoking, sedentary behavior, and poor sleep further worsen cardiovascular risk."
    ],
    "Conclusion": "The CHOL/HDL ratio is elevated. Aggressive lifestyle modifications are recommended, and pharmacologic therapy should be considered to reduce cardiovascular risk. If untreated, the risk of heart attack and stroke increases significantly."
  },
  "SGPT/ALT": {
    "Range": [7, 56],
    "Current Level": "42 U/L",
    "Age": {
      "Baby (0-2 years)": "N/A",
      "Child (3-12 years)": "N/A",
      "Young Adult (20-35 years)": "7–56 U/L",
      "Adult (36-64 years)": "7–56 U/L",
      "Senior (65+ years)": "7–56 U/L"
    },
    "Sex": {
      "Male": "7–56 U/L",
      "Female": "7–56 U/L"
    },
    "Medication": "Silymarin",
    "Dosage": {
      "Young Adult (20-35 years)": "Silymarin 140 mg three times daily with meals.",
      "Adult (36-64 years)": "Silymarin 140 mg three times daily with meals.",
      "Senior (65+ years)": "Silymarin 140 mg twice daily; adjust based on tolerance."
    },
    "Count": "15",
    "Treatment": "As treated",
    "Reason": [
      "A mild elevation in ALT may indicate transient hepatic stress from poor diet, alcohol consumption, or medications.",
      "Additional factors such as inadequate sleep and smoking can further impair liver function."
    ],
    "Conclusion": "ALT is marginally elevated. Recommend liver‑friendly dietary changes, avoidance of alcohol and smoking, and consider Silymarin supplementation. If not treated, persistent elevation may lead to progressive liver damage."
  },
  "SGOT/AST": {
    "Range": [10, 40],
    "Current Level": "21 U/L",
    "Age": {
      "Baby (0-2 years)": "N/A",
      "Child (3-12 years)": "N/A",
      "Young Adult (20-35 years)": "10–40 U/L",
      "Adult (36-64 years)": "10–40 U/L",
      "Senior (65+ years)": "10–40 U/L"
    },
    "Sex": {
      "Male": "10–40 U/L",
      "Female": "10–40 U/L"
    },
    "Medication": "No medication required.",
    "Dosage": {
      "Standard": "Not applicable."
    },
    "Count": "0",
    "Treatment": "Daily maintenance",
    "Reason": [
      "Normal AST indicates preserved liver and muscle function."
    ],
    "Conclusion": "AST is normal. Continue a balanced diet, regular exercise, and avoid factors such as alcohol abuse and smoking to maintain muscle and liver health."
  },
  "HbA1C": {
    "Range": [4.0, 5.6],
    "Current Level": "6.6 %",
    "Age": {
      "Baby (0-2 years)": "N/A",
      "Child (3-12 years)": "N/A",
      "Young Adult (20-35 years)": "4.0–5.6 %",
      "Adult (36-64 years)": "4.0–5.6 %",
      "Senior (65+ years)": "4.0–5.6 %"
    },
    "Sex": {
      "Male": "4.0–5.6 %",
      "Female": "4.0–5.6 %"
    },
    "Medication": "Metformin",
    "Dosage": {
      "Young Adult (20-35 years)": "Metformin 500 mg twice daily with meals; titrate based on glycemic response.",
      "Adult (36-64 years)": "Metformin 500 mg three times",
      "Senior (65+ years)": "Metformin 500 mg twice daily with meals; start low and titrate cautiously."
    },
    "Count": "15",
    "Treatment": "As treated",
    "Reason": [
      "An elevated HbA1C indicates chronic hyperglycemia and increased risk for diabetic complications.",
      "Additional contributing factors such as insufficient sleep, smoking, and heavy alcohol use can worsen glycemic control.",
      "Without treatment, there is a significant risk for microvascular (neuropathy, retinopathy, nephropathy) and macrovascular (cardiovascular) complications."
    ],
    "Conclusion": "HbA1C is elevated, suggesting impaired long‑term glycemic control. Intensify lifestyle modifications (improve sleep, cease smoking, reduce alcohol intake) and initiate metformin therapy to prevent serious diabetic complications."
  },
  "Sodium": {
    "Range": [135, 145],
    "Current Level": "137 mEq/L",
    "Age": {
      "Baby (0-2 years)": "135–145 mEq/L",
      "Child (3-12 years)": "135–145 mEq/L",
      "Young Adult (20-35 years)": "135–145 mEq/L",
      "Adult (36-64 years)": "135–145 mEq/L",
      "Senior (65+ years)": "135–145 mEq/L"
    },
    "Sex": {
      "Male": "135–145 mEq/L",
      "Female": "135–145 mEq/L"
    },
    "Medication": "No medication required.",
    "Dosage": {
      "Standard": "Not applicable."
    },
    "Count": "0",
    "Treatment": "Daily maintenance",
    "Reason": [
      "Sodium within this range confirms proper fluid and electrolyte balance."
    ],
    "Conclusion": "Sodium is normal. Maintain adequate hydration and routine electrolyte monitoring to avoid imbalances."
  },
  "Potassium": {
    "Range": [3.5, 5.0],
    "Current Level": "4.2 mEq/L",
    "Age": {
      "Baby (0-2 years)": "3.5–5.0 mEq/L",
      "Child (3-12 years)": "3.5–5.0 mEq/L",
      "Young Adult (20-35 years)": "3.5–5.0 mEq/L",
      "Adult (36-64 years)": "3.5–5.0 mEq/L",
      "Senior (65+ years)": "3.5–5.0 mEq/L"
    },
    "Sex": {
      "Male": "3.5–5.0 mEq/L",
      "Female": "3.5–5.0 mEq/L"
    },
    "Medication": "No medication required if within normal limits.",
    "Dosage": {
      "Standard": "Not applicable.",
      "If Hypokalemia": "Oral potassium chloride 20–40 mEq every 8 hours or IV potassium chloride 10–20 mEq per hour (with monitoring)."
    },
    "Count": "0",
    "Treatment": "Daily maintenance",
    "Reason": [
      "Normal potassium is vital for proper muscle function and nerve conduction."
    ],
    "Conclusion": "Potassium is normal. Continue a balanced diet to sustain electrolyte equilibrium."
  },
  "WBC": {
    "Range": [4.0, 11.0],
    "Current Level": "6.2 x 10^3/μL",
    "Age": {
      "Baby (0-2 years)": "6.0–17.5 x 10^3/μL",
      "Child (3-12 years)": "5.0–13.0 x 10^3/μL",
      "Young Adult (20-35 years)": "4.0–11.0 x 10^3/μL",
      "Adult (36-64 years)": "4.0–11.0 x 10^3/μL",
      "Senior (65+ years)": "4.0–11.0 x 10^3/μL"
    },
    "Sex": {
      "Male": "4.0–11.0 x 10^3/μL",
      "Female": "4.0–11.0 x 10^3/μL"
    },
    "Medication": "No medication required.",
    "Dosage": {
      "Standard": "Not applicable."
    },
    "Count": "0",
    "Treatment": "Daily maintenance",
    "Reason": [
      "A normal WBC count indicates a properly functioning immune system."
    ],
    "Conclusion": "WBC is within normal limits. No intervention is necessary."
  },
  "Calcium": {
    "Range": [8.5, 10.2],
    "Current Level": "9.4 mg/dL",
    "Age": {
      "Baby (0-2 years)": "8.5–10.5 mg/dL",
      "Child (3-12 years)": "8.5–10.5 mg/dL",
      "Young Adult (20-35 years)": "8.5–10.2 mg/dL",
      "Adult (36-64 years)": "8.5–10.2 mg/dL",
      "Senior (65+ years)": "8.5–10.2 mg/dL"
    },
    "Sex": {
      "Male": "8.5–10.2 mg/dL",
      "Female": "8.5–10.2 mg/dL"
    },
    "Medication": "Calcium supplementation only if a deficiency is documented.",
    "Dosage": {
      "Low Calcium": "Typically 500–1000 mg of elemental calcium daily, divided into 2–3 doses."
    },
    "Count": "30",
    "Treatment": "As treated",
    "Reason": [
      "Calcium is essential for bone health and neuromuscular function.",
      "Insufficient calcium over time can lead to osteoporosis and increased fracture risk."
    ],
    "Conclusion": "Calcium is normal. Supplement only if a deficiency is confirmed; untreated deficiency can lead to decreased bone density and fractures."
  },
  "Magnesium": {
    "Range": [1.7, 2.2],
    "Current Level": "2.0 mg/dL",
    "Age": {
      "Baby (0-2 years)": "1.5–2.5 mg/dL",
      "Child (3-12 years)": "1.5–2.5 mg/dL",
      "Young Adult (20-35 years)": "1.7–2.2 mg/dL",
      "Adult (36-64 years)": "1.7–2.2 mg/dL",
      "Senior (65+ years)": "1.7–2.2 mg/dL"
    },
    "Sex": {
      "Male": "1.7–2.2 mg/dL",
      "Female": "1.7–2.2 mg/dL"
    },
    "Medication": "Magnesium supplementation if levels are low.",
    "Dosage": {
      "Low Magnesium": "200–400 mg daily, adjusted based on clinical response."
    },
    "Count": "0",
    "Treatment": "As treated",
    "Reason": [
      "Magnesium is critical for muscle and nerve function and energy metabolism.",
      "Chronic deficiency may result in muscle cramps, arrhythmias, and fatigue."
    ],
    "Conclusion": "Magnesium is within normal limits. Ensure adequate dietary intake; untreated deficiency can lead to neuromuscular and cardiovascular issues."
  },
  "Phosphorus": {
    "Range": [2.5, 4.5],
    "Current Level": "3.2 mg/dL",
    "Age": {
      "Baby (0-2 years)": "3.5–6.0 mg/dL",
      "Child (3-12 years)": "3.0–5.0 mg/dL",
      "Young Adult (20-35 years)": "2.5–4.5 mg/dL",
      "Adult (36-64 years)": "2.5–4.5 mg/dL",
      "Senior (65+ years)": "2.5–4.5 mg/dL"
    },
    "Sex": {
      "Male": "2.5–4.5 mg/dL",
      "Female": "2.5–4.5 mg/dL"
    },
    "Medication": "Phosphorus supplementation only if a deficiency is confirmed.",
    "Dosage": {
      "Low Phosphorus": "Dosage should be individualized based on the severity of deficiency."
    },
    "Count": "0",
    "Treatment": "As treated",
    "Reason": [
      "Phosphorus is vital for cellular energy and bone mineralization.",
      "Untreated deficiency can lead to muscle weakness and osteomalacia."
    ],
    "Conclusion": "Phosphorus is within normal limits. No supplementation is required; untreated deficiency may impair bone and cellular function."
  },
  "Albumin": {
    "Range": [3.5, 5.0],
    "Current Level": "4.1 g/dL",
    "Age": {
      "Baby (0-2 years)": "3.5–5.5 g/dL",
      "Child (3-12 years)": "3.5–5.0 g/dL",
      "Young Adult (20-35 years)": "3.5–5.0 g/dL",
      "Adult (36-64 years)": "3.5–5.0 g/dL",
      "Senior (65+ years)": "3.5–5.0 g/dL"
    },
    "Sex": {
      "Male": "3.5–5.0 g/dL",
      "Female": "3.5–5.0 g/dL"
    },
    "Medication": "No medication required if albumin is normal.",
    "Dosage": {
      "Standard": "Not applicable."
    },
    "Count": "0",
    "Treatment": "Daily maintenance",
    "Reason": [
      "Albumin is a marker of liver synthetic function and nutritional status.",
      "Low albumin can indicate malnutrition or liver disease."
    ],
    "Conclusion": "Albumin is within normal limits. Maintain a balanced diet to support optimal nutritional status. Untreated low albumin can lead to edema and poor wound healing."
  },
  "Bilirubin": {
    "Range": [0.1, 1.2],
    "Current Level": "0.8 mg/dL",
    "Age": {
      "Baby (0-2 years)": "0.1–1.0 mg/dL",
      "Child (3-12 years)": "0.1–1.0 mg/dL",
      "Young Adult (20-35 years)": "0.1–1.2 mg/dL",
      "Adult (36-64 years)": "0.1–1.2 mg/dL",
      "Senior (65+ years)": "0.1–1.2 mg/dL"
    },
    "Sex": {
      "Male": "0.1–1.2 mg/dL",
      "Female": "0.1–1.2 mg/dL"
    },
    "Medication": "No medication required if bilirubin is normal.",
    "Dosage": {
      "Standard": "Not applicable."
    },
    "Count": "0",
    "Treatment": "Daily maintenance",
    "Reason": [
      "Normal bilirubin indicates effective hepatic clearance and normal red blood cell turnover."
    ],
    "Conclusion": "Bilirubin is normal. No treatment is necessary; untreated abnormalities can indicate liver dysfunction."
  }
}
